194 related articles for article (PubMed ID: 32015161)
1. DPP4 Inhibition, NPY
Jackson EK; Gillespie DG; Tofovic SP
J Pharmacol Exp Ther; 2020 Apr; 373(1):135-148. PubMed ID: 32015161
[TBL] [Abstract][Full Text] [Related]
2. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
Zhu X; Gillespie DG; Jackson EK
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
[TBL] [Abstract][Full Text] [Related]
3. SDF-1α (Stromal Cell-Derived Factor 1α) Induces Cardiac Fibroblasts, Renal Microvascular Smooth Muscle Cells, and Glomerular Mesangial Cells to Proliferate, Cause Hypertrophy, and Produce Collagen.
Jackson EK; Zhang Y; Gillespie DD; Zhu X; Cheng D; Jackson TC
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29114002
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Jackson EK; Kochanek SJ; Gillespie DG
Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.
Jackson EK; Mi E; Ritov VB; Gillespie DG
Hypertension; 2018 Oct; 72(4):909-917. PubMed ID: 30354710
[TBL] [Abstract][Full Text] [Related]
6. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
Jackson EK; Mi Z; Tofovic SP; Gillespie DG
Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
[TBL] [Abstract][Full Text] [Related]
7. Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells.
Cheng D; Zhu X; Gillespie DG; Jackson EK
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F770-80. PubMed ID: 23303411
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats.
Jackson EK; Zhang M; Liu W; Mi Z
J Pharmacol Exp Ther; 2007 Nov; 323(2):431-7. PubMed ID: 17726157
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
11. A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
Kawase H; Bando YK; Nishimura K; Aoyama M; Monji A; Murohara T
J Mol Cell Cardiol; 2016 Sep; 98():37-47. PubMed ID: 27374118
[TBL] [Abstract][Full Text] [Related]
12. Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition.
Tofovic SP; Salah EM; Dubey RK; Melhem MF; Jackson EK
J Cardiovasc Pharmacol; 2005 Jul; 46(1):25-35. PubMed ID: 15965351
[TBL] [Abstract][Full Text] [Related]
13. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
Jackson EK; Mi Z
Hypertension; 2008 Jun; 51(6):1637-42. PubMed ID: 18443229
[TBL] [Abstract][Full Text] [Related]
14. The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Chiazza F; Tammen H; Pintana H; Lietzau G; Collino M; Nyström T; Klein T; Darsalia V; Patrone C
Cardiovasc Diabetol; 2018 May; 17(1):60. PubMed ID: 29776406
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.
Mentlein R; Dahms P; Grandt D; Krüger R
Regul Pept; 1993 Dec; 49(2):133-44. PubMed ID: 7907802
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Dipeptidyl Peptidase 4 Inhibition Worsens Hypertension and Renal and Cardiac Abnormalities in Obese Spontaneously Hypertensive Heart Failure Rats.
Jackson EK; Mi Z; Gillespie DG; Cheng D; Tofovic SP
J Am Heart Assoc; 2021 Mar; 10(6):e020088. PubMed ID: 33682436
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
[TBL] [Abstract][Full Text] [Related]
19. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.
Jost MM; Lamerz J; Tammen H; Menzel C; De Meester I; Lambeir AM; Augustyns K; Scharpé S; Zucht HD; Rose H; Jürgens M; Schulz-Knappe P; Budde P
Biochem Pharmacol; 2009 Jan; 77(2):228-37. PubMed ID: 18940185
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α
Lovshin JA; Rajasekeran H; Lytvyn Y; Lovblom LE; Khan S; Alemu R; Locke A; Lai V; He H; Hittle L; Wang W; Drucker DJ; Cherney DZI
Diabetes Care; 2017 Aug; 40(8):1073-1081. PubMed ID: 28550195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
